Shopping Cart
  • Remove All
  • TargetMol
    Your shopping cart is currently empty
Filter
Applied FilterClear all
TargetMol | Tags By Target
  • Apoptosis
    (6)
  • NF-κB
    (5)
  • COX
    (2)
  • Epigenetic Reader Domain
    (2)
  • ASK
    (1)
  • Antifection
    (1)
  • Beta Amyloid
    (1)
  • CCR
    (1)
  • CaMK
    (1)
  • Others
    (7)
Filter
Search Result
Results for "

p50

" in TargetMol Product Catalog
  • Inhibitors & Agonists
    19
    TargetMol | Inhibitors_Agonists
  • Compound Libraries
    1
    TargetMol | Compound_Libraries
  • Peptide Products
    4
    TargetMol | Peptide_Products
  • PROTAC Products
    1
    TargetMol | PROTAC
  • Natural Products
    4
    TargetMol | Natural_Products
  • Recombinant Protein
    13
    TargetMol | Recombinant_Protein
  • Antibody Products
    25
    TargetMol | Antibody_Products
Mangiferin
Hedysarid, Chinomin, Alpizarin
T30124773-96-0
Mangiferin (Hedysarid) is used for antidiabetes. Extracted from Mangifera indica L.
  • $38
In Stock
Size
QTY
TargetMol | Citations Cited
Effusanin E
TN392276470-15-0
Effusanin E shows antibacterial and anti-cancer activities, it significantly inhibits cell proliferation and induces apoptosis in NPC cells by suppressing p50 p65 proteins to down-regulate COX-2 expression .
  • Inquiry Price
Size
QTY
Neoechinulin A
TN463551551-29-2
Neoechinulin A has anti-inflammatory effect against LPS-stimulated RAW264.7 macrophages through inhibition of the NF-κB and p38 MAPK pathways, it may block the phosphorylation of mitogen-activated protein kinase (MAPK) molecule p38, apoptosis signal-regu
  • $620
Backorder
Size
QTY
Kamebakaurin
Kamebakaurine
TWS197773981-34-7
1. Kamebakaurin (Kamebakaurine) has the ability to protect the liver from APAP-induced hepatotoxicity, presumably by both inhibiting the inflammatory response and oxidative stress. 2. Kamebakaurin inhibits the expression of hypoxia-inducible factor-1α and its target genes to confer antitumor activity. 3. Kamebakaurin has anti-cancer and anti-inflammatory activities through direct inhibition of DNA-binding activity of nuclear factor-kappa B (NF-κB) p50.4. Kamebakaurin has anti-neuroinflammatory activity via inhibition of c-Jun NH -terminal kinase and p38 mitogen-activated protein kinase pathway in activated microglial cells.
  • $100
In Stock
Size
QTY